umu.sePublications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Five-year results of nordic T1G2-3, a randomized trial comparing bcg with epirubicin and interferon alpha 2b
Umeå University, Faculty of Medicine, Department of Radiation Sciences, Oncology.
Show others and affiliations
2013 (English)In: Scandinavian journal of urology, ISSN 2168-1805, Vol. 47, no Suppl. 219, 19-20 p.Article in journal, Meeting abstract (Other academic) Published
Place, publisher, year, edition, pages
2013. Vol. 47, no Suppl. 219, 19-20 p.
National Category
Urology and Nephrology
Identifiers
URN: urn:nbn:se:umu:diva-81021ISI: 000323611300021OAI: oai:DiVA.org:umu-81021DiVA: diva2:652339
Available from: 2013-09-30 Created: 2013-09-30 Last updated: 2013-09-30Bibliographically approved

Open Access in DiVA

No full text

Authority records BETA

Johansson, Robert

Search in DiVA

By author/editor
Johansson, Robert
By organisation
Oncology
Urology and Nephrology

Search outside of DiVA

GoogleGoogle Scholar

urn-nbn

Altmetric score

urn-nbn
Total: 111 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf